Local immune status and tumour marker expression in the human larynx.
This study examined the local immune status and tumour marker expression in secretions and related tissue specimens from the laryngeal ventricle, comparing individuals with and without head and neck cancer. Laryngeal secretion and mucosal tissue specimens were collected during laryngeal microsurgery or surgical laryngectomy. The laryngeal secretions were found to contain immunological factors such as immunoglobulins G and A and secretory immunoglobulin A. A high level of the tumour marker Cyfra 21-1 was also detected in laryngeal secretions and mucosal tissue. Lows levels of secretory immunoglobulin A and Cyfra 21-1 were seen in the laryngeal mucosal tissue of controls and patients who had previously undergone radiation therapy. The level of secretory immunoglobulin A in laryngeal secretions closely correlated to the level of this immunoglobulin in mucosal tissue. These results indicate that local immunity is present in the human larynx; furthermore, it is strongly affected both by the presence of malignancy and by laryngeal cancer treatments such as irradiation.
Nakashima
T
T
Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan. orlkaku@med.kurume-u.ac.jp
Tomita
H
H
Chitose
S
S
Umeno
H
H
Sato
K
K
D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology*; D014408:Biomarkers, Tumor / Q000032:analysis / Q000276:immunology*; D005260:Female; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000032:analysis / Q000276:immunology*; D053539:Keratin-19 / Q000032:analysis / Q000276:immunology*; D007822:Laryngeal Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000601:surgery; D007830:Larynx / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008875:Middle Aged
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D007071:Immunoglobulin A, Secretory; D053539:Keratin-19; C102012:antigen CYFRA21.1